14 January 2021
Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Tobias Rodehau Lead | Pinsent Masons | Partner | corporate | Not stated |
| Dr. Anke Empting | Pinsent Masons | Not stated | public and regulatory | Not stated |
| Dr. Michael Reich | Pinsent Masons | Partner | commercial and IP | Not stated |
| Dr. Florian von Baum | Pinsent Masons | Not stated | technology, science and industry | Not stated |
| Marc Holtorf | Pinsent Masons | Not stated | IP | Not stated |
| Dr. Igor Barabash | Pinsent Masons | Not stated | commercial | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Not stated